As of December 2024, Sumitomo Dainippon Pharma has a market cap of $1.61B. This makes Sumitomo Dainippon Pharma the world's 5938th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $985.88M | -24.03% |
2023 | $1.30B | -53.35% |
2022 | $2.78B | -24.60% |
2021 | $3.69B | -13.00% |
2020 | $4.24B | -28.50% |
2019 | $5.93B | -39.06% |
2018 | $9.73B | 108.78% |
2017 | $4.66B | -16.72% |
2016 | $5.60B | 40.46% |
2015 | $3.99B | 22.20% |
2014 | $3.26B | -28.81% |
2013 | $4.58B | 58.94% |
2012 | $2.88B | 18.02% |
2011 | $2.44B | 18.83% |
2010 | $2.06B | -24.39% |
2009 | $2.72B | 17.31% |
2008 | $2.32B | 1.71% |
2007 | $2.28B | -40.90% |
2006 | $3.85B | 25.25% |
2005 | $3.08B | 7.18% |
2004 | $2.87B | 40.27% |
2003 | $2.05B | -25.91% |
2002 | $2.76B | -25.41% |
2001 | $3.70B | -29.63% |
2000 | $5.26B | - |